Search

everythinglearnresearchcommunity

for

Search:↓

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

Male pattern baldness involves hormones and cell signals affecting hair growth.

The T-zone on the face has more androgen receptors and produces more oil than the U-zone.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

Mice with human gene experienced hair loss when treated with DHT.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Researchers created a cell line to study hair growth and found specific genes affected by dihydrotestosterone.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

A gene called HDAC9 might be a new factor in male-pattern baldness.

Androgens increase a growth factor in hair cells by creating reactive oxygen species, and antioxidants might help treat hair loss.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Dosing time affects finasteride's effectiveness and safety in rats.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

A yeast-based test can detect the steroid methyltestosterone in urine longer than traditional methods.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.